Parenteral nutrition solution w/electrolytes Interactions
There are 81 drugs known to interact with parenteral nutrition solution w/electrolytes, along with 1 disease interaction. Of the total drug interactions, 27 are major, 40 are moderate, and14 are minor.
- View all 81 medications that may interact with parenteral nutrition solution w/electrolytes
- View parenteral nutrition solution w/electrolytes disease interactions (1)
Most frequently checked interactions
View interaction reports for parenteral nutrition solution w/electrolytes and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Akynzeo (netupitant / palonosetron)
- Allegra (fexofenadine)
- AmBisome (amphotericin b liposomal)
- Aquaphor (emollients topical)
- Avelox I.V. (moxifloxacin)
- Azactam (aztreonam)
- Bactrim (sulfamethoxazole / trimethoprim)
- Belbuca (buprenorphine)
- Benadryl (diphenhydramine)
- Blincyto (blinatumomab)
- BuSpar (buspirone)
- Calpol Six Plus (acetaminophen)
- Cancidas (caspofungin)
- Carafate (sucralfate)
- Cequa (cyclosporine ophthalmic)
- ChloraPrep One-Step (chlorhexidine topical)
- Cipro (ciprofloxacin)
- CoQ10 (ubiquinone)
- Corlanor (ivabradine)
- Cubicin (daptomycin)
- Cytovene (ganciclovir)
- Desferal (deferoxamine)
- Dilantin (phenytoin)
- Duac (benzoyl peroxide / clindamycin topical)
- Emend for Injection (fosaprepitant)
- Entyvio (vedolizumab)
- Epogen (epoetin alfa)
- Merrem (meropenem)
- Protonix IV (pantoprazole)
Parenteral nutrition solution w/electrolytes disease interactions
There is 1 disease interaction with parenteral nutrition solution w/electrolytes which include:
More about parenteral nutrition solution w/electrolytes
- parenteral nutrition solution w/electrolytes consumer information
- Compare alternatives
- Side effects
- Drug class: intravenous nutritional products
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.